Serbian scientist and professor Milica Bajčetić is the winner of the prestigious international International Medis Awards for Medical Research in the field of pharmacy, which was presented last night at a ceremony in Ljubljana.
As reported by the Slovenian portal 24ur.com, this recognition is considered one of the most significant for medical research in Central and Eastern Europe, which is why the media often call it the “medical Oscar”. The award is given to doctors and pharmacists who, alongside their daily clinical work, achieve exceptional results in scientific research and publish papers in international medical journals.
According to the organizers, the international expert jury this year reviewed more than 240 scientific papers from 11 European countries. After a months-long evaluation process, 18 researchers reached the final and competed in nine different medical fields.
In the pharmacy category, the award was won precisely by the Serbian scientist Milica Bajčetić, which gave Serbia one of the laureates of this year’s ceremony. The expert jury evaluated her work as a significant contribution to the development of modern pharmacotherapy and the improvement of drug safety, especially in the field of pediatric medicine.
FIND OUT MORE:
According to Slovenian media, the awarded scientific paper focuses on improving therapeutic approaches and developing new pharmaceutical formulations that can enhance patient treatment, particularly for the youngest patients.
“It is a great honor and privilege to be the recipient of this prestigious award. It is confirmation both of my work and of the work of the entire ‘Lena’ project team. Our research has made a significant contribution to improving pharmacotherapy for newborns worldwide. This first innovative formulation of enalapril has been clinically tested for the treatment of heart failure. The solid tablet form adapted to age will particularly help children in environments that do not have access to running water and live in extreme climate zones. This award further motivates me to continue research that will enable children to have safe, effective and high-quality therapy,” emphasized Prof. Dr. Bajčetić.
The ceremony announcing the winners was held on March 12 in Ljubljana, with the presence of numerous doctors, scientists and representatives of the academic community from several European countries. It should be noted that not all finalists were present.
The awards were presented to researchers whose work contributes to the advancement of medicine, the development of new therapies and the improvement of the quality of healthcare.
The International Medis Awards for Medical Research was established in order to recognize and promote top scientific achievements of doctors and pharmacists from Central and Eastern Europe, and the laureates of this recognition often gain significant international visibility in scientific circles.
Slovenian media assess that this year’s ceremony once again confirmed the importance of regional cooperation in medical research, as well as the growing contribution of scientists from the region to the development of modern medicine.
The International Medis Awards for Medical Research was established in 2014 and is awarded to doctors and pharmacists who, alongside clinical work, publish top scientific research in international journals. The goal of the recognition is to promote scientific excellence and advance the development of medicine in the countries of Central and Eastern Europe.
We remind that the research of Prof. Dr. Milica Bajčetić deals with a long-standing problem in the treatment of heart failure in young children – the lack of ready-made, age-appropriate oral medicines for children under six years old. Children with congenital heart defects or dilated cardiomyopathy often have to receive therapy with drugs such as enalapril, but these medicines for the youngest patients do not exist in an appropriate form.
MORE TOPICS:
Source: Kurir; Foto: Privatna arhiva